Sanofis

Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of …

MedWatchUS FDA grants priority review for Sanofi’s type 1 diabetes drugFrance is seeking fast-track approval of diabetes drug Tzield in children aged over one..2 hours ago

Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetes If approved, Tzield would be the first disease-modifying therapy to delay the …

Nov 14 (Reuters) – The European Medicines Agency’s committee has recommended approval of French drugmaker Sanofi’s (SASY.PA)opens new tab first-of-its-kind drug that delays onset of the insulin-dependent stage 3 of …